Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Conditions

Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Colorectal Neoplasms 3Recurrence 2Carcinoma, Non-Small-Cell Lung 2Stage IIIb and IV Non Small Cell Lung Cancer 1Solid Tumor, Adult 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplastic Syndromes, Hereditary 1Mouth Neoplasms 1Microsatellite Instability 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hereditary Breast and Ovarian Cancer Syndrome 1Head and Neck Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Medullary 1COVID-19 1Breast Neoplasms 1Biliary Tract Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Surgical Procedures, Operative 7Liver Transplantation 5Lenalidomide 4Blood Specimen Collection 4pomalidomide 3Neoadjuvant Therapy 3Liquid Biopsy 3gilteritinib 2Therapeutics 2Rituximab 2Proteasome Inhibitors 2Observation 2Mohs Surgery 2Mitomycin 2Magnetic Resonance Spectroscopy 2Immunotherapy, Adoptive 2Immunoconjugates 2High-Throughput Nucleotide Sequencing 2Fluorouracil 2Drug Therapy 2DNA, Mitochondrial 2Brentuximab Vedotin 2Bendamustine Hydrochloride 2Antibodies, Monoclonal 2Antibodies, Bispecific 2Amplified Fragment Length Polymorphism Analysis 2trametinib 1romidepsin 1nedaplatin 1lenvatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Recurrence × High-Throughput Nucleotide Sequencing × Clear all
NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Recruiting
3,500 enrolled

Neoplasms, Recurrence

NCT05483257 2022-08-02

Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

Ruijin Hospital

Completed
226 enrolled

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡